A detailed history of Group One Trading, L.P. transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 7,873 shares of MORF stock, worth $448,682. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,873
Holding current value
$448,682
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$26.12 - $34.07 $205,642 - $268,233
7,873 New
7,873 $268,000
Q2 2023

Aug 09, 2023

SELL
$34.33 - $62.11 $62,789 - $113,599
-1,829 Reduced 76.88%
550 $31,000
Q1 2023

May 12, 2023

BUY
$26.01 - $48.69 $61,877 - $115,833
2,379 New
2,379 $89,000
Q2 2022

Aug 11, 2022

SELL
$19.74 - $43.01 $27,635 - $60,214
-1,400 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$36.25 - $52.02 $50,750 - $72,828
1,400 New
1,400 $56,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.